Rationally designing safer anilines: The challenging case of 4-aminobiphenyls

Journal of Medicinal Chemistry

Volumn 55, Issue 8, 2012, Pages 3923-3933

  Birch, Alan M ^a   Groombridge, Sam ^a   Law, Robert ^a   Leach, Andrew G ^a   Mee, Christine D ^a   Schramm, Carolin ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE; ANTIDIABETIC AGENT;

AMES TEST; ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; QUANTUM MECHANICS; STRUCTURE ACTIVITY RELATION;

AMINOBIPHENYL COMPOUNDS; ANILINE COMPOUNDS; DNA DAMAGE; DRUG DESIGN; MOLECULAR CONFORMATION; MUTAGENICITY TESTS; QUANTUM THEORY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84860278568     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm3001295     Document Type: Article

References (36)

1. Leach, A. G.; Cann, R.; Tomasi, S. Reaction energies computed with density functional theory correspond with a whole organism effect; modelling the Ames test for mutagenicity Chem. Commun. (Cambridge, U. K.) 2009, 1094-1096
2. Some Aromatic Amines, Organic Dyes, and Related Exposures; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 99; International Agency for Research on Cancer: Lyon, France, 2010; pp 1-658.
3. ICH Expert Working Group. Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH S2(R1); ICH: Geneva, 2011.
4. Ames, B. N.; Whitfield, H. J., Jr. Frameshift mutagenesis in Salmonella Cold Spring Harbor Symp. Quant. Biol. 1966, 31, 221-225
5. Ames, B. N.; Lee, F. D.; Durston, W. E. Improved bacterial test system for the detection and classification of mutagens and carcinogens Proc. Nat. Acad. Sci. U.S.A. 1973, 70, 782-786
6. Mortelmans, K.; Zeiger, E. The Ames Salmonella/microsome mutagenicity assay Mutat. Res. 2000, 455, 29-60
7. Easterbrook, J.; Fackett, D.; Li, A. P. A comparison of Aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4′-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6β-hydroxylation Chem.-Biol. Interact 2001, 134, 243-249 (Pubitemid 32406147)
8. Beland, F. A.; Kadlubar, F. F. Formation and persistence of arylamine DNA adducts in vivo Environ. Health Perspect. 1985, 62, 19-30 (Pubitemid 16188399)
9. Kadlubar, F. F.; Beland, F. A. Chemical properties of ultimate carcinogenic metabolites of arylamines and arylamides ACS Symp. Ser. 1985, 283, 341-370
10. Wild, D. A novel pathway to the ultimate mutagens of aromatic amino and nitro compounds Environ. Health Perspect. 1990, 88, 27-31 (Pubitemid 20352942)
11. Turesky, R. J.; Guengerich, F. P.; Guillouzo, A.; Langouet, S. Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2 Mutat. Res., Fundam. Mol. Mech. Mutagen. 2002, 506-507, 187-195 (Pubitemid 35286553)
12. Novak, M.; Rajagopal, S. Correlations of nitrenium ion selectivities with quantitative mutagenicity and carcinogenicity of the corresponding amines Chem. Res. Toxicol. 2002, 15, 1495-1503 (Pubitemid 36008197)
13. Borosky, G. L. Ultimate carcinogenic metabolites from aromatic and heterocyclic aromatic amines: a computational study in relation to their mutagenic potency Chem. Res. Toxicol. 2007, 20, 171-180 (Pubitemid 46408853)
14. Borosky, G. L. Carcinogenic carbocyclic and heterocyclic aromatic amines: a DFT study concerning their mutagenic potency J. Mol. Graphics Modell. 2008, 27, 459-465
15. Himmelstein, M. W.; Boogaard, P. J.; Cadet, J.; Farmer, P. B.; Kim, J. H.; Martin, E. A.; Persaud, R.; Shuker, D. E. G. Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage Crit. Rev. Toxicol. 2009, 39, 679-694
16. Siraki, A. G.; Chan, T. S.; Galati, G.; Teng, S.; O'Brien, P. J. N-Oxidation of aromatic amines by intracellular oxidases Drug Metab. Rev. 2002, 34, 549-564 (Pubitemid 35012001)
17. McBriar, M. D.; Guzik, H.; Shapiro, S.; Paruchova, J.; Xu, R.; Palani, A.; Clader, J. W.; Cox, K.; Greenlee, W. J.; Hawes, B. E.; Kowalski, T. J.; O'Neill, K.; Spar, B. D.; Weig, B.; Weston, D. J.; Farley, C.; Cook, J. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas J. Med. Chem. 2006, 49, 2294-2310
18. Bentzien, J.; Hickey, E. R.; Kemper, R. A.; Brewer, M. L.; Dyekjaer, J. D.; East, S. P.; Whittaker, M. An in silico method for predicting ames activities of primary aromatic amines by calculating the stabilities of nitrenium ions J. Chem. Inf. Model. 2010, 50, 274-297
19. Block, M. H.; Boyer, S.; Brailsford, W.; Brittain, D. R.; Carroll, D.; Chapman, S.; Clarke, D. S.; Donald, C. S.; Foote, K. M.; Godfrey, L.; Ladner, A.; Marsham, P. R.; Masters, D. J.; Mee, C. D.; O'Donovan, M. R.; Pease, J. E.; Pickup, A. G.; Rayner, J. W.; Roberts, A.; Schofield, P.; Suleman, A.; Turnbull, A. V. Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity J. Med. Chem. 2002, 45, 3509-3523 (Pubitemid 34824039)
20. Hamann, L. G.; Manfredi, M. C.; Sun, C.; Krystek, S. R.; Huang, Y.; Bi, Y.; Augeri, D. J.; Wang, T.; Zou, Y.; Betebenner, D. A.; Fura, A.; Seethala, R.; Golla, R.; Kuhns, J. E.; Lupisella, J. A.; Darienzo, C. J.; Custer, L. L.; Price, J. L.; Johnson, J. M.; Biller, S. A.; Zahler, R.; Ostrowski, J. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N -aryl bicyclic hydantoin-based selective androgen receptor modulators Bioorg. Med. Chem. Lett. 2007, 17, 1860-1864 (Pubitemid 46367685)
21. Borosky, G. L. Quantum chemical studies on ultimate carcinogenic metabolites from polycyclic aromatic hydrocarbons Curr. Med. Chem. 2008, 15, 2901-2920
22. McCarren, P.; Bebernitz, G. R.; Gedeck, P.; Glowienke, S.; Grondine, M. S.; Kirman, L. C.; Klickstein, J.; Schuster, H. F.; Whitehead, L. Avoidance of the Ames test liability for aryl-amines via computation Bioorg. Med. Chem. 2011, 19, 3173-3182
23. Lennox, A. J. J.; Lloyd-Jones, G. C. The slow-release strategy in Suzuki-Miyaura coupling Isr. J. Chem. 2010, 50, 664-674
24. Plowright, A. T.; Johnstone, C.; Kihlberg, J.; Pettersson, J.; Robb, G.; Thompson, R. A. Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle Drug Discovery Today 2012, 17, 56-62
25. JMP, version 8; SAS Institute Inc.: Cary, NC.
26. Becke, A. D. Density-functional thermochemistry. III. The role of exact exchange J. Chem. Phys. 1993, 98, 5648-5652
27. Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density Phys. Rev. B: Condens. Matter 1988, 37, 785-789
28. Hariharan, P. C.; Pople, J. A. Influence of polarization functions on MO hydrogenation energies Theor. Chim. Acta 1973, 28, 213-222
29. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, N. J.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, revision A.1; Gaussian, Inc.: Wallingford, CT, 2009.
30. Box, G. E. P. Empirical Model-Building and Response Surfaces; Wiley: New York, 1987.
31. O'Donovan, M. R.; Mee, C. D.; Fenner, S.; Teasdale, A.; Phillips, D. H. Boronic acids: a novel class of bacterial mutagen Mutat. Res., Genet. Toxicol. Environ. Mutagen. 2011, 724, 1-6
32. Hansch, C.; Leo, A.; Unger, S. H.; Kim, K. H.; Nikaitani, D.; Lien, E. J. Aromatic substituent constants for structure-activity correlations J. Med. Chem. 1973, 16, 1207-1216
33. Waring, M. J. Defining optimum lipophilicity and molecular weight ranges for drug candidates: molecular weight dependent lower log D limits based on permeability Bioorg. Med. Chem. Lett. 2009, 19, 2844-2851
34. Camenisch, G.; Alsenz, J.; van de Waterbeemd, H.; Folkers, G. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight Eur. J. Pharm. Sci 1998, 6, 313-319 (Pubitemid 28468539)
35. Maron, D. M.; Ames, B. N. Revised methods for the Salmonella mutagenicity test Mutat. Res., Environ. Mutagen. Relat. Subj. 1983, 113, 173-215 (Pubitemid 13120319)
36. CORINA, Molecular Networks; GmbH Computer Chemie Langemarckplatz 1: Erlangen, Germany.